Receivables Days: The Red Flag Metric That Reveals Whether Indian Companies Are Getting Paid on Time — Or Heading Toward a Cash Crisis

Why Profitable Companies Still Go Bankrupt — And the One Metric That Warns You in Advance

Here is a scenario that has played out hundreds of times in Indian stock markets: a company reports rising revenues, growing profits, and an impressive order book. The stock price climbs. Retail investors pile in. Then, seemingly out of nowhere, the company announces a cash crunch, delays in debt repayment, or worse — defaults on its obligations. The stock crashes 60-80% in weeks.

What happened? The answer, more often than not, lies in a metric that 95% of retail investors never bother checking: Receivables Days (also known as Debtor Days or Days Sales Outstanding).

Today, with the Sensex closing at 71,948 and the Nifty at 22,331 amid a sharp 2.2% selloff driven by the ongoing US-Iran conflict, it is more critical than ever to focus on business quality rather than market noise. And receivables days is one of the most powerful quality indicators available to you — for free, on any screener.

What Are Receivables Days? The Simple Explanation

Receivables Days measures how many days, on average, a company takes to collect payment from its customers after making a sale. When a company sells goods worth ₹10 lakh to a buyer on credit, the buyer does not pay immediately. The time gap between the sale and the actual cash collection is your receivables days.

The Formula:

Receivables Days = (Trade Receivables ÷ Revenue from Operations) × 365

For example, if a company has ₹50 crore in trade receivables and ₹200 crore in annual revenue, its receivables days = (50 ÷ 200) × 365 = 91 days. This means the company waits, on average, three full months to get paid after delivering goods or services.

Why Receivables Days Matter More Than You Think

Most retail investors focus on revenue growth and net profit. But here is the uncomfortable truth: revenue recorded in the profit and loss statement is not the same as cash received. Under accrual accounting, a company records revenue the moment it delivers goods — whether or not it has been paid. This creates a dangerous gap between paper profits and actual cash in the bank.

High receivables days can signal several serious problems:

1. Weak Bargaining Power: If a company cannot get its customers to pay on time, it suggests the company has limited pricing power or is operating in an intensely competitive market where customers dictate terms. Compare this with a company like Asian Paints, which collects from its dealer network within 30-40 days because of its dominant brand power.

2. Revenue Recognition Games: Some companies stuff the channel — pushing products to distributors at quarter-end to inflate revenue numbers. This shows up as ballooning receivables. If you see revenue growing at 20% but receivables growing at 50%, something is very wrong.

3. Customer Concentration Risk: If a company depends on a few large customers (especially government entities), receivables can stretch to 120-180 days or more. Government payment delays have destroyed shareholder value in countless Indian infrastructure and defense companies.

4. Working Capital Strain: Every day a company waits for payment, it still needs to pay its suppliers, employees, and lenders. High receivables days create a working capital hole that must be filled with debt — eating into returns.

The Receivables Days Benchmark — What Is Good in India?

There is no universal answer because receivables days vary dramatically by industry. Here is a practical framework for Indian investors:

Excellent (Under 30 days): Cash-and-carry businesses, strong B2C brands, dominant players. Think FMCG companies like Hindustan Unilever or Nestle India, which get paid almost immediately because they sell to millions of consumers through distributors who pay quickly.

Good (30-60 days): Businesses with reasonable credit terms and strong relationships. Many well-run IT companies, specialty chemical players, and consumer durables firms fall here. Titan Biotech (BSE: 524717), for instance, currently trading around ₹370 with a market cap of approximately ₹1,890 crore and promoter holding steady at 55.8%, operates in the B2B biotech ingredients space. In B2B businesses, 30-60 day receivables are perfectly healthy and show disciplined customer management.

Manageable (60-90 days): Common in capital goods, engineering, and some pharmaceutical companies. Not ideal, but acceptable if the trend is stable and the company generates enough cash flow to fund operations.

Dangerous (90-150 days): A serious red flag. This means a company waits 3-5 months to get paid. Common in infrastructure, construction, and companies with heavy government exposure. If receivables days are this high AND increasing, run.

Critical (Above 150 days): The company is essentially funding its customers businesses. Cash flow will be severely impacted. Many companies with 150+ day receivables eventually face write-offs, provisions for bad debts, or outright defaults. Quick Heal Technologies, for example, saw receivables exceed 150 days in FY2020 — a clear warning sign that operational challenges were mounting.

How to Analyse Receivables Days: The 5-Step Framework

Step 1: Calculate the Trend Over 5 Years

A single year number means nothing. What matters is the direction. Pull up five years of data from Screener.in or Trendlyne and plot the receivables days. If receivables days have gone from 45 to 50 to 58 to 72 to 95 over five years, that is a deteriorating trend — and a warning that the business is losing its ability to collect cash efficiently. Conversely, if receivables days are declining from 90 to 75 to 60 to 50, the company is strengthening its position.

Step 2: Compare With Industry Peers

Always compare receivables days within the same industry. An IT services company with 75-day receivables might be poorly managed, while a construction company with the same number might actually be best-in-class. Context is everything. Pull up 3-4 direct competitors on Screener.in and compare side by side.

Step 3: Check Receivables Growth vs Revenue Growth

This is the single most important test. If revenue grows 15% but receivables grow 40%, the company is almost certainly sacrificing cash collection quality for top-line growth. This is how value traps are created — companies that look like they are growing but are actually just accumulating IOUs from customers who may never pay.

Step 4: Read the Annual Report Notes

In the notes to financial statements, companies must disclose their trade receivables ageing. This breaks down receivables into buckets: less than 6 months, 6-12 months, 1-2 years, 2-3 years, and beyond 3 years. If a significant portion of receivables is older than one year, that is stale inventory on the balance sheet — money the company may never collect. This often precedes a large write-off that demolishes earnings.

Step 5: Connect With Cash Flow from Operations

High receivables days almost always correlate with weak operating cash flow. If a company reports ₹100 crore in net profit but only ₹30 crore in cash flow from operations, the gap is often explained by rising receivables.

Real-World Red Flags — Indian Companies Destroyed by Rising Receivables

Case Study 1: Infrastructure and EPC Companies

India infrastructure sector is notorious for high receivables. Companies like IL&FS had massive receivables from government projects that took years to pay. When the cash crunch hit in 2018, the entire house of cards collapsed, wiping out thousands of crores in investor wealth. The warning signs were visible in receivables data years before the crisis.

Case Study 2: Power Sector Nightmares

Several power generation and distribution companies saw receivables balloon to 200+ days as state electricity boards delayed payments. Companies like Suzlon Energy experienced severe cash flow stress partly because their receivables kept climbing while they needed to service massive debt loads.

Case Study 3: The Small-Cap Trap

Many small-cap companies that report impressive revenue growth are actually just piling up receivables. They show a beautiful P&L statement while the balance sheet quietly deteriorates. By the time the market realizes the cash is not coming in, the stock has already collapsed. This is why Manish Goel always emphasises looking beyond the P&L to the balance sheet and cash flow statement.

Titan Biotech — A Case Study in Disciplined Collections

At Multibagger Shares, Titan Biotech (BSE: 524717) remains our conviction pick, and its receivables management is one reason why. As a B2B biotech ingredients company serving the pharmaceutical, food, and diagnostic industries, Titan Biotech maintains receivables in a healthy range relative to its sector.

With revenue of approximately ₹193 crore and profit of ₹27.2 crore, the company ability to maintain operational discipline while growing its top line reflects the kind of business quality that creates long-term wealth. The stock, currently around ₹370 (post its 5:1 stock split in February 2026), has delivered extraordinary returns — up over 326% in the past year — because the underlying business fundamentals are genuinely strong, not because of accounting tricks or inflated receivables.

The promoter holding at 55.8% further reinforces confidence: the Goel family is deeply invested in the business and has every incentive to maintain conservative financial practices, including disciplined receivables management.

The Receivables Days Checklist for Indian Value Investors

Before you buy any stock, add these checks to your analysis process:

✅ Calculate receivables days for the last 5 years — is the trend stable or declining?
✅ Compare with 3-4 industry peers — is the company best-in-class or worst?
✅ Check if receivables are growing faster than revenue — if yes, that is a red flag
✅ Read the trade receivables ageing schedule in the annual report
✅ Verify that operating cash flow is at least 70-80% of net profit — if not, check receivables
✅ Be extra cautious with government-dependent businesses (infrastructure, defense, power)
✅ Avoid companies where receivables days exceed 120 unless you have a very strong thesis

A Warning About F&O Gambling — SEBI Data Speaks

While we are discussing fundamentals-based investing, let us remind ourselves why this approach matters. SEBI own data shows that over 90% of individual traders in Futures and Options lose money. F&O trading does not require you to understand receivables days, cash conversion cycles, or business quality. It is pure speculation dressed up as investing.

Real wealth creation — the kind that turns ₹1 lakh into ₹1 crore over 15-20 years — comes from buying high-quality businesses at reasonable prices and holding them. Understanding metrics like receivables days helps you separate genuinely good businesses from those that merely appear good on the surface.

If you want to learn value investing systematically, check out our complete free value investing course on YouTube.

Today Market Context: Why Fundamentals Matter More Than Ever

Today, on the last trading day of FY2025-26, the Indian market witnessed a brutal selloff. The Sensex plunged 1,636 points (2.22%) to close at 71,948, while the Nifty crashed 488 points (2.14%) to settle at 22,331. The US-Iran military conflict continues to weigh on global sentiment, and the RBI recent tightening of bank dollar position limits added to the negative mood.

On days like these, it is tempting to panic. But this is exactly when fundamental analysis protects you. If you own companies with low receivables days, strong cash flows, and disciplined management, market selloffs are opportunities — not threats.

Choose quality. Analyse deeply. Think long-term. That is the Multibagger Shares way.

Disclaimer: This article is for educational purposes only and does not constitute financial advice. The author (Manish Goel) is a SEBI Registered Research Analyst (Registration No. INH100004775) and Multibagger Shares (Multibagger Securities Research & Advisory Pvt. Ltd.) is a SEBI Registered Investment Advisor (Registration No. INA100007736). Multibagger Shares is a SEBI-registered entity. This article is purely educational and should not be construed as a buy/sell recommendation. Titan Biotech is discussed as an educational case study; the author may hold positions in stocks mentioned. Always do your own research and consult a qualified financial advisor before making investment decisions. Stock market investments are subject to market risks. Past performance does not guarantee future returns.

Manish Goel

Manish Goel is a Chartered Accountant, SEBI-registered Investment Advisor, and founder of Multibagger Shares. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

See Full Bio